EarlySense gets $25M as it continues push toward homeJun. 2, 2016
Ramat Gan, Israel-based EarlySense, which makes a passive and contactless bedside monitor that continuously measures respiration rate, heart rate, and motion, has raised $25 million in new funding in a round led by Bank Hapoalim, Israel’s largest bank. Pitango Venture Capital, JK&B Capital, and other previous investors also contributed to the round.
“We are experiencing exponential growth in the medical space and this funding enables us to continue to grow as well as launch consumer digital health offerings based on our medically proven technology," Avner Halperin, CEO of EarlySense, said in a statement. “More than one hundred thousand patients will be monitored with our sensors this year, allowing for better care. There is a real need to bring these capabilities to individuals and their family members at home. In expanding the reach of EarlySense, we can potentially impact millions of lives in both the medical and wellness markets.”
This brings the company’s total funding to $100 million, including a strategic investment from Samsung. Samsung is marketing a version of EarlySense’s first direct-to-consumer device, a sleep monitoring device called myEarlySense, marketed by Samsung under the name Sleep Sense. Sleep Sense was supposed to be available in the US by the end of 2015, but doesn't appear to be available yet.